O'Brien BJ - Search Results

1

Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. Drummond MF, et al. JAMA. 1997 May 21;277(19):1552-7. doi: 10.1001/jama.277.19.1552. JAMA. 1997. PMID: 9153371 No abstract available.

2

Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.

O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. O'Brien BJ, et al. JAMA. 1997 Jun 11;277(22):1802-6. doi: 10.1001/jama.277.22.1802. JAMA. 1997. PMID: 9178794 No abstract available.

3

Clinical importance, statistical significance and the assessment of economic and quality-of-life outcomes.

Drummond M, O'Brien B. Drummond M, et al. Health Econ. 1993 Oct;2(3):205-12. doi: 10.1002/hec.4730020303. Health Econ. 1993. PMID: 8275165

4

Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.

Reed SD, Anstrom KJ, Bakhai A, Briggs AH, Califf RM, Cohen DJ, Drummond MF, Glick HA, Gnanasakthy A, Hlatky MA, O'Brien BJ, Torti FM Jr, Tsiatis AA, Willan AR, Mark DB, Schulman KA. Reed SD, et al. Am Heart J. 2005 Mar;149(3):434-43. doi: 10.1016/j.ahj.2004.11.001. Am Heart J. 2005. PMID: 15864231

5

Economic analysis alongside clinical trials: practical considerations. The Economics Workgroup.

Drummond M, O'Brien B. Drummond M, et al. J Rheumatol. 1995 Jul;22(7):1418-9. J Rheumatol. 1995. PMID: 7562789 Review. No abstract available.

6

Cost-benefit analyses in the health-care literature: don't judge a study by its label.

Zarnke KB, Levine MA, O'Brien BJ. Zarnke KB, et al. J Clin Epidemiol. 1997 Jul;50(7):813-22. doi: 10.1016/s0895-4356(97)00064-4. J Clin Epidemiol. 1997. PMID: 9253393 Review.

7

Statistical versus quantitative significance in the socioeconomic evaluation of medicines.

O'Brien BJ, Drummond MF. O'Brien BJ, et al. Pharmacoeconomics. 1994 May;5(5):389-98. doi: 10.2165/00019053-199405050-00005. Pharmacoeconomics. 1994. PMID: 10147230 Review.

8

Effectiveness, efficiency, and NICE.

Sculpher M, Drummond M, O'Brien B. Sculpher M, et al. BMJ. 2001 Apr 21;322(7292):943-4. doi: 10.1136/bmj.322.7292.943. BMJ. 2001. PMID: 11312215 Free PMC article. No abstract available.

9

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.

O'Brien BJ, Drummond MF, Labelle RJ, Willan A. O'Brien BJ, et al. Med Care. 1994 Feb;32(2):150-63. doi: 10.1097/00005650-199402000-00006. Med Care. 1994. PMID: 8302107

10

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M. O'Brien B, et al. Arch Intern Med. 1999 Oct 25;159(19):2298-304. doi: 10.1001/archinte.159.19.2298. Arch Intern Med. 1999. PMID: 10547169 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters